Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose, Effects and Characteristics of Pilocarpine
NCT00803803Phase 4Completed
- Sponsor
- Wills Eye Hospital
- Start
- Aug 1978
- Primary completion
- Aug 1979
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pilocarpine in open-angle glaucoma (OAG) (2 arms), sponsored by Wills Eye Hospital. Primary endpoint: Intraocular Pressure at 25 days. Started Aug 1978; status: completed.
02
Drugs
pilocarpine
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT00803803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803803.